$8.70
+0.26(3.08%)
Mkt Cap $73M
$7.09
$16.50
52-Week Range
At a Glance
AI-generatedA challenging year marked by widening operating losses and significant cash burn, as the pre-revenue company invested in R&D and staffing while management explicitly flagged substantial doubt about its ability to continue as a going concern.
$73M
Market Cap
—
Revenue
-$8M
Net Income
Employees31
Fundamentals
How The Business Makes Money
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
Industry Biotechnology
Activity
What Changed Recently
Company Profile
CIK0002010788
ISINUS4618741098
Phone626 415 1488
Address750 Royal Oaks Drive, Monrovia, NV, 91016, US
SEC EDGAR